[Concentration determinations and clinical effectiveness of doxycycline (Vibramycin) in the uterus, adnexa and maternal milk].
D000328:Adult; D005187:Fallopian Tubes / Q000032:analysis*; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D008875:Middle Aged; D008895:Milk, Human / Q000032:analysis*; D010053:Ovary / Q000032:analysis*; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy; D049590:Postpartum Period; D011247:Pregnancy; D013752:Tetracycline / Q000032:analysis* / Q000097:blood / Q000627:therapeutic use; D014599:Uterus / Q000032:analysis*
D013752:Tetracycline
Konzentrationsbestimmungen und klinische Wirksamkeit von Doxycyclin (Vibramycin) in Uterus, Adnexen und Muttermilch.